Angela Walsh
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Dogwood Therapeutics, Inc. (DWTX)
Proxy statement
Current -
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Dogwood Therapeutics, Inc. (DWTX) | Chief Financial Officer | $300,910 | $1,252,051 |
| 2024 | Dogwood Therapeutics, Inc. (DWTX) | Chief Financial Officer | $239,625 | $364,328 |
| 2023 | Dogwood Therapeutics, Inc. (DWTX) | Chief Financial Officer | $242,351 | $282,639 |
| 2022 | Dogwood Therapeutics, Inc. (DWTX) | Senior Vice President of Finance | $242,351 | $426,816 |
| 2021 | Dogwood Therapeutics, Inc. (DWTX) | Senior Vice President of Finance | $213,525 | $413,802 |
| 2019 | Dogwood Therapeutics, Inc. (DWTX) | Vice President of Finance | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.